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Venous thrombosis is a frequently occurring disorder, commonly localized in
the deep veins of the legs and often found in combination with pulmonary
embolism. The risk of deep vein thrombosis is increased in all conditions that
are associated with a diminished blood flow in the veins, injury of the vessel
wall and/or a disturbance of the balance between the pro- and anticogulant
systems in favour of the procoagulant system. The latter has been recognized
as an important contributive mechanism of thrombosis in patients with
'hereditary thrombophilia'. Hereditary deficiencies of the circulating
anticoagulant proteins antithrombin III, protein C and protein S and increased
resistance to activated protein C (APC-resistance) are the most frequently
found causes of hereditary thrombophilia. Diagnosis of these hereditary
abnormalities should only been made by handling strict criteria. In this way,
the chance of misdiagnosis or confusion with acquired, usually temporary
abnormalities can be kept as small as possible.
This thesis deals with the results of studies on the clinical expression of
inherited and acquired deficiencies of protein C and protein S and of APC-
resistance; of studies on the effects of age, sex and hormonal state on plasma
levels of pro- and anticoagulant proteins and thereby on their normal ranges
and mutual balance; and of studies on the effects of these conditions on APC-
ratio or APC-sensitivity ratio (APC-SR) as a measure for APC-resistance.
ln chapter I the pro- and anticoagulant systems are shortly described. An
overview is given of the most frequently found causes of hereditary
thrombophil ia, their incidences, cl inical presentation, therapeutic
implications and laboratory diagnosis. Some conditions or abnormalities
that may result in acquired thrombophilia are discussed.
In chapter 2we describe a study in 103 first-degree relatives of l3 symptomatic
heterozygous protein C or protein S-deficient patients in order to assess the
effects oi (l ) exposure to concomitant risk factors and[2] differences in levels
of protein C and protein S on the clinical expression of these deficiencies. In
37 relatives protein C deficiency was diagnosed and in 20 relatives protein S
deficiency. Fourty-six relatives had no deficiency. At least one thromboembolic
event had occurred in 30% of protein C-deficient and 35% of protein S-
deficient relatives. These were only 3 o/o and}o/o, respectively, in normal first-
degree relatives. Oi the first thromboembolic events, 36% in protein C-
deficient and29o/o in protein S-deficient relatives occurred in the presence of
secondary risk f actors like surgery, pregnancy/puerperium, immob llization,
varicosis oruse of oral contraceptives. These were 64% and5O7o, respectively,
when thromboembolic events had recurred. The symptomatic deficient
103
relatives had a simiiar degree of deficiency as their asymptomatic deficient
relatives. These results show that secondary risk factors play a substantial
role in the clinical expression of deficiencies whereas the latter seems to be
independent of the degree of deficiency in heterozygous deficiencies of pro-
tein C or protein S.
In chapter 3 coagulation abnormalities are described which were found in
children, several months to years after they underwent Fontan-type cardiac
surgery for correction of congenital heart defects. Abnormalities were found
in24 of.37 investigated patients, of which a deficiency of protein C was the
most common and pronounced. Five patients had an isolated protein C
deficiency, one an isolated factor X deficiency and the remaining l8 patients
all had combinations of deficiencies of procoagulant as well as anticoagulant
factors. The patients with a protein C deficiency differed not from those
without with respect to type of cardiac surgery, type of congenital heart
defect, cardiac function and liver function. Two of 2l patients with protein
C deficiency had a severe thromboembolic event, as well as one of the four
patients with protein S deficiency. The high frequency of thromboemboiic
events in these patients suggests an increased thrombotic risk due to the
observed, acquired imbalance between their pro- and anticoagulant systems.
Chapter 4 describes a study in 393 healthy blood donors to assess the
influences of sex, hormonal state and age on the plasma levels of protein C,
total and free protein S and factor X. In men all measured proteins showed
higher levels than in women. Also, all measured proteins were higher in
postmenopausal women as compared to premenopausal women. In multiple
regression analysis the classification 'men', 'premenopausal women' and
/postmenopausal women', as well as age showed to be of influence on the
levels of protein C, total and free protein S. Of these, age was not related to
the level of factor X. These results suggest a regulating role of sex-hormones
on levels of pro- and anticoagulant factors which should be taken into
account in daily clinical practice. As a consequence, dif{erent normal ranges
for men, pre- and postmenopausal women have to be considered.
In the first part of. chapter 5, the influence of sex and oral contraceptives on
the sensitivity to activated protein C, expressed as APC-ratio, is described.
The APC-ratio was measured in 43 men, 42 wornen not using oral contra-
ceptives and 38 women using oral contraceptives which contained 30.0-37.5
pg ethinyl estradiol. In men, APC-ratio showeci to be higher as compared to
womenwho did andwomenwho didnotuse oral contraceptives. Thewomen
using oral contraceptives had lower APC-ratios than women not using oral
contraceptives, 18.4% o{ the former group had an APC-ratio below the lower
limit of normal. These data demonstrate an influence of sex and estrogen-
women using oral contraceptives is not necessarily associated with inherited
APC-resistance.
In the second part of this chapter we have tried to find a possible explanation
for the differences in APC-ratio between men and women and for the effect
o{ oral contraceptives on APC-ratio. We measured the clotting activity of the
coagulation factors V and VIII as well as levels of protein S. In women using
oral contraceptives, factor VIII levels were higher and factor V and protein S
levels were lower/ as compared to men. In multiple regression analysis, levels
of the clotting activity of factor VIII as well as the classification in groups (i.e.
men/ women not using oral contraceptives and women using oral
contraceptivesI showed to be independent variables with respect o the APC-
ratio. The relation with factor VIII was inverse, that is the higher factor VIII,
the lower APC-ratio. The latter was confirmed by an in vitro experiment.
In chapter 6 we report on a study in neurosurgical patients, that was conducted
to assess the relation between decreased APC-SR and postoperative venous
thromboemboiism. Serial measurements of APC-SR, protein C, factor V and
factor VIII were done and venography was performed in all patients to
demonstrate deep vein thrombosis. In l0 of 41 patients deep vein thrombosis
was diagnosed by venography at the end of the follow-up period. Mean APC-
SR was decreased and the mean level of factor VIII increased prior to surgery
in both patients who did and those who did not develop deep vein thrombosis.
Postoperative changes were similar in both groups; APC-SR further decreased
and levels of factors V and MII as well as protein C increased. In multiple
regression analysis APC-SR could not be identified as an independent risk
{actor for deep vein thrombosis, nor were levels of factors V and VIII and
protein C. Only sex and overweight were related to the occunence of throm-
bosis. Women ha d a 12 times higher risk of thrombosis than men and patients
with overweight an l8 times higher risk. Although a decreased APC-SR was
demonstrated in the majority of these patients, suggesting acquired APC-
resistance, it was not associated with the risk of postoperative thrombosis. In
this study, APC-SR again showed to be inversely related to FMII as well as to
protein C.
Conclusions:
1. Secondary risk factors play a substantial role in the clinical expression
of hereditary deficiencies of protein C and protein S, as they provoke
venous thromboemboiism in a considerable amount of these patients.
For this reason, thromboprophylaxis should be considered during periods
of exposure to these risk factors. The use of oral contraceptives should
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